Richard Christopher

Insider Reports History

Entity
Individual
Location
C/O Lucid, Inc., 50 Methodist Hill Dr, Suite 1000, Rochester, NY
Signature
/Richard Christopher/
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Christopher:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lexaria Bioscience Corp. Chief Executive Officer common shares 50K $124K $2.47 Dec 3, 2024 Direct
Lexaria Bioscience Corp. Chief Executive Officer Stock Options 200K Dec 2, 2024 Direct
INVIVO THERAPEUTICS HOLDINGS CORP. Chief Financial Officer Stock Option (right to buy) 20.8K Nov 17, 2022 Direct

Insider Reports Filed by Richard Christopher

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LEXX Lexaria Bioscience Corp. Dec 2, 2024 2 $118K 4 Dec 3, 2024 Chief Executive Officer
LEXX Lexaria Bioscience Corp. Aug 31, 2024 0 $0 3 Sep 5, 2024 Chief Executive Officer
NVIV INVIVO THERAPEUTICS HOLDINGS CORP. Nov 17, 2022 1 $0 4 Nov 21, 2022 Chief Financial Officer